These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Are we ready to manage an opioid epidemic in the intensive care unit? Das A; Sharma A; Kothari N; Goyal S Anaesthesiol Intensive Ther; 2022; 54(3):271-278. PubMed ID: 36062420 [TBL] [Abstract][Full Text] [Related]
5. Comparison of demographic and clinical characteristics between opioid-dependent individuals admitted to a community-based treatment setting and those enrolled in a research-based treatment setting. Carroll CP; Kidorf M; Strain EC; Brooner RK J Subst Abuse Treat; 2007 Dec; 33(4):355-61. PubMed ID: 17400415 [TBL] [Abstract][Full Text] [Related]
6. Paradoxical role of cytochrome P450 3A in the bioactivation and clinical effects of levo-alpha-acetylmethadol: importance of clinical investigations to validate in vitro drug metabolism studies. Kharasch ED; Whittington D; Hoffer C; Krudys K; Craig K; Vicini P; Sheffels P; Lalovic B Clin Pharmacokinet; 2005; 44(7):731-51. PubMed ID: 15966756 [TBL] [Abstract][Full Text] [Related]
7. Treatment of heroin (diamorphine) addiction: current approaches and future prospects. Gonzalez G; Oliveto A; Kosten TR Drugs; 2002; 62(9):1331-43. PubMed ID: 12076182 [TBL] [Abstract][Full Text] [Related]
8. [New drugs for substitution treatment of opioid dependence. Buprenorphine and 1-alpha-acetylmethadol (LAAM) ]. Petersen H; Skauge L; Svejsø J; Ege PP Ugeskr Laeger; 2000 Nov; 162(48):6553-6. PubMed ID: 11187226 [TBL] [Abstract][Full Text] [Related]
9. Rx: 3x/week LAAM: alternative to methadone. Clinical studies: Phase I. Sollod RM; Goldstein MG NIDA Res Monogr; 1976 Jul; (8):39-51. PubMed ID: 11418 [No Abstract] [Full Text] [Related]
10. Induction with levomethadyl acetate: safety and efficacy. Jones HE; Strain EC; Bigelow GE; Walsh SL; Stitzer ML; Eissenberg T; Johnson RE Arch Gen Psychiatry; 1998 Aug; 55(8):729-36. PubMed ID: 9707384 [TBL] [Abstract][Full Text] [Related]
11. A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence. Johnson RE; Chutuape MA; Strain EC; Walsh SL; Stitzer ML; Bigelow GE N Engl J Med; 2000 Nov; 343(18):1290-7. PubMed ID: 11058673 [TBL] [Abstract][Full Text] [Related]
12. Dose-related efficacy of levomethadyl acetate for treatment of opioid dependence. A randomized clinical trial. Eissenberg T; Bigelow GE; Strain EC; Walsh SL; Brooner RK; Stitzer ML; Johnson RE JAMA; 1997 Jun; 277(24):1945-51. PubMed ID: 9200635 [TBL] [Abstract][Full Text] [Related]
13. A randomized, open-label trial comparing methadone and Levo-Alpha-Acetylmethadol (LAAM) in maintenance treatment of opioid addiction. Wolstein J; Gastpar M; Finkbeiner T; Heinrich C; Heitkamp R; Poehlke T; Scherbaum N Pharmacopsychiatry; 2009 Jan; 42(1):1-8. PubMed ID: 19153939 [TBL] [Abstract][Full Text] [Related]
14. Relative potency of levo-alpha-acetylmethadol and methadone in humans under acute dosing conditions. Eissenberg T; Stitzer ML; Bigelow GE; Buchhalter AR; Walsh SL J Pharmacol Exp Ther; 1999 May; 289(2):936-45. PubMed ID: 10215673 [TBL] [Abstract][Full Text] [Related]
15. Retention rate and illicit opioid use during methadone maintenance interventions: a meta-analysis. Farré M; Mas A; Torrens M; Moreno V; Camí J Drug Alcohol Depend; 2002 Feb; 65(3):283-90. PubMed ID: 11841899 [TBL] [Abstract][Full Text] [Related]